Similar articles

• [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].

  Inaguma D, Tatematsu M. Inaguma D, et al. Clin Calcium. 2009 Apr;19(4):493-9. Clin Calcium. 2009. PMID: 19329827 Review. Japanese.
• 1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?

  Fournier A, Moriniere P, Boudaillez B, Renaud H, Marie A, Westeel PF, Hocine C, Belbrik S. Fournier A, et al. Nephrol Dial Transplant. 1987;2(6):498-503. Nephrol Dial Transplant. 1987. PMID: 3126450 Review. No abstract available.
• Economic impact of vitamin D treatment on chronic kidney disease patients.

  Ramos R, Alcázar R, Otero A, de Francisco AL, del Pino MD. Ramos R, et al. Nefrologia. 2011;31(5):528-36. doi: 10.3265/Nefrologia.pre2011.Aug.11012. Nefrologia. 2011. PMID: 21959719 English, Spanish.
• Chronic kidney disease--mineral and bone disorder: a complex scenario.

  Mejía N, Roman-García P, Miar AB, Tavira B, Cannata-Andía JB. Mejía N, et al. Nefrologia. 2011;31(5):514-9. doi: 10.3265/Nefrologia.pre2011.Jun.10926. Nefrologia. 2011. PMID: 21959717 Review. English, Spanish.
• [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].

  Fournier A, Aparicio M. Fournier A, et al. Nephrologie. 1998;19(3):129-30. Nephrologie. 1998. PMID: 9633056 French. No abstract available.